[MedTech] Advanced Clinical Innovation Specialist - Heart Recovery

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in pharmaceutical, medical devices and diagnostics markets, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://www.jnj.com/ .

1.

포지션 : Advanced Clinical Innovation Specialist
2.

계열사 : 존슨앤드존슨 메드테크 (MedTech)
3.

근무지 : 서울시 용산구
4.

근무 형태 : Regular

[Summary]

The main responsibility of the ACIS , Korea is to establish Impella & Heart Recovery as new Standard of Care in an assigned region by transferring clinical support and training best practices and operating mechanisms and therapy development toolkits to the Korea Commercial Team.

[Responsibilities]

1.

Develop Heart Recovery Clinical Team:

As a primary responsibility Design and Implement a Sign off process for the Korea Heart Recovery Commercial Team.

Ensure Sign-off process and training milestones are compliantly adhered to will be responsible for designing, implementing and conducting comprehensive advanced training programs on our existing and future product portfolio, product enhancements and new indications.

They are the cardiac and surgical subject matter expert for the APAC clinical field teams and customers, providing on-site resource during cases in OR and/or ICU, Cathlab.

2.

Therapy Development:

Establishing Impella as the standard of care for Heart Recovery in Korea will be achieved through training MDs & hospital staff about the appropriate use of Impella through protocols and consensus ensuring excellent clinical outcomes.

Establish peer-to-peer networks across the region to share best practices from APAC to Korea.

Plan regular visits to all institutions with active Impella programs to monitor activity and collect clinically relevant data.

Staff and follow up major conferences & local heart failure symposiums meaningfully in partnership with Marketing and peer to peer education.

3.

Account Management / Account Training:

Partner with the Korea Impella Commercial Team to use APAC account selection criteria to identify the correct accounts to begin partnership on the Impella therapy.

Enable and drive our patient growth and clinical performance in key centres for approved indications.

Coordinate our strategy with commercial team, set an example and lead clinical activities and establish transparent case reporting consistent with Asia Pacific practices.

Initiate and coordinate Heart Recovery customer training programs to develop/expand physician skills to drive the Impella adoption in active sites as well in new sites.

Provide frameworks for hospital consensus and protocols of therapy.

4...